Life-Sciences-France.com
The French Life Sciences Web Portal

This is a free web portal for the life sciences in France and Monaco... » read more

Ipsen Acquires Memo Tx for up to >€700m with €200m Upfront (2026-07-01)
> Acquisition focused on clinical-stage program potravitug, a first-in-class BK polyomavirus monoclonal antibody > Totality of evidence from the Phase II SAFE KIDNEY II trial supports initiation of pivotal Phase II/III trial later this year > Ipsen expands ra...
KyooBe’s Pathogen Inactivation Available via Fraunhofer IZI (2026-06-30)
Recent infectious disease events—from hantavirus outbreaks and meningitis cases to recurring disease outbreaks in livestock farming—highlight the need for flexibly scalable vaccine manufacturing processes. To address this challenge, Stuttgart-based technology c...
Jeito & Sofinnova Co-lead $165m Series A of Bionyra (2026-06-22)
> Series A co-led by Jeito Capital and Sofinnova Partners, with participation from Arkin Bio, Sanofi Ventures, Sixty Degree Capital, Vives Partners and Apollo Health Ventures > Sofinnova Partners seed financed and co-founded Bionyra alongside Frédéric Marrache...
Graph Therapeutics Raises $5m Investment Led by Daphni (2026-06-22)
Graph Therapeutics (“Graph”) announces that Daphni, the Paris-based venture capital firm, has joined Graph’s investor syndicate to accelerate its internal pipeline. Daphni invests alongside continued participation from existing investors SquareOne, Merantix C...
TrueLab Biopharma Licenses Two Antibodies to Bionyra (2026-06-22)
TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million TrueLab Biopharmaceutical, an immunology-driven innovator l...
Ona Therapeutics Raises $86.6mSeries B to Advance ADCs (2026-06-04)
> Oversubscribed Series B financing co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors > Proceeds to support clinical development of lea...
Olix Pharma Secures KRW110b Investment from BOLD and Weiss (2026-06-04)
> Participation of both strategic partner and key global investor > Underlines the potential of OliX Pharmaceuticals’ siRNA platform OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that it has raised...
Lauxera Capital Partners Closes Growth II Fund at €520m (2026-05-19)
The oversubscribed second fund plans to deploy capital across 12 to 15 companies, with individual investments of €20 to €50 million focused on US and global market expansion. Lauxera Capital Partners, a growth-buyout and growth equity firm focused on innov...
Sensorion Appoints Fred Chereau as Chief Executive Officer (2026-05-18)
> Fred Chereau brings extensive leadership experience across the biotechnology and pharmaceutical industries, with deep expertise in gene therapy and company building, driven by a lifelong commitment to patients with rare diseases. > Fred joins from Alexion – ...
CellCentric Announces $220m Series D Led by Venrock (2026-05-06)
> Proceeds to support registration-enabling trials, DOMMINO-1 and DOMMINO-2, and continued development of the first-in-class p300/CBP inhibitor > Financing led by Venrock Healthcare Capital Partners, with participation from Fidelity Management & Research Company...

Life-Sciences-France.com is your doorway to the French life sciences!

[LSF] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in France and Monaco.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)